192 related articles for article (PubMed ID: 12056700)
1. Raltitrexed: current clinical status and future directions.
Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
[TBL] [Abstract][Full Text] [Related]
2. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
Caponigro F; Avallone A; Budillon A; Comella P; Comella G
Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
[TBL] [Abstract][Full Text] [Related]
4. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
Carnaghi C; Zucali P; Garassino I
Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
[TBL] [Abstract][Full Text] [Related]
5. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
Armand JP; Seymour L; Evans TR
Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
[TBL] [Abstract][Full Text] [Related]
6. Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.
Van Cutsem E
Eur J Cancer; 1999 Mar; 35 Suppl 1():S1-2. PubMed ID: 10645206
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin: a new therapeutic option in colorectal cancer.
Cvitkovic E; Bekradda M
Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
[TBL] [Abstract][Full Text] [Related]
8. Raltitrexed in mesothelioma.
Surmont VF; van Meerbeeck JP
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1481-90. PubMed ID: 21999120
[TBL] [Abstract][Full Text] [Related]
9. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').
Blackledge G
Br J Cancer; 1998; 77 Suppl 2(Suppl 2):29-37. PubMed ID: 9579853
[TBL] [Abstract][Full Text] [Related]
10. Future developments with 'Tomudex' (raltitrexed).
Van Cutsem E
Anticancer Drugs; 1997 Aug; 8 Suppl 2():S33-8. PubMed ID: 9376636
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
Cao S; Bhattacharya A; Durrani FA; Fakih M
Expert Opin Pharmacother; 2006 Apr; 7(6):687-703. PubMed ID: 16556086
[TBL] [Abstract][Full Text] [Related]
12. Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy.
Scheithauer W; Kornek GV; Schuell B; Ulrich-Pur H; Penz M; Raderer M; Lang F; Schneeweiss B; Lenauer A; Depisch D
Ann Oncol; 2001 May; 12(5):709-14. PubMed ID: 11432632
[TBL] [Abstract][Full Text] [Related]
13. Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.
Fizazi K; Ducreux M; Ruffié P; Bonnay M; Daniel C; Soria JC; Hill C; Fandi A; Poterre M; Smith M; Armand JP
J Clin Oncol; 2000 Jun; 18(11):2293-300. PubMed ID: 10829050
[TBL] [Abstract][Full Text] [Related]
14. Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma.
Fizazi K; Caliandro R; Soulié P; Fandi A; Daniel C; Bedin A; Doubre H; Viala J; Rodier J; Trandafir L; Le Chevalier T; Cvitkovic E; Armand J; Ruffié P
Eur J Cancer; 2000 Aug; 36(12):1514-21. PubMed ID: 10930799
[TBL] [Abstract][Full Text] [Related]
15. Mature results from three large controlled studies with raltitrexed ('Tomudex').
Cunningham D
Br J Cancer; 1998; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
[TBL] [Abstract][Full Text] [Related]
16. New oxaliplatin-based combinations in the treatment of colorectal cancer.
Cassidy J; Hochster H
Colorectal Dis; 2003 Nov; 5 Suppl 3():1-9. PubMed ID: 23573555
[TBL] [Abstract][Full Text] [Related]
17. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.
Schwartz GK; Harstrick A; González Barón M
Eur J Cancer; 1999 Mar; 35 Suppl 1():S9-13. PubMed ID: 10645208
[TBL] [Abstract][Full Text] [Related]
18. Combination of raltitrexed with other cytotoxic agents: rationale and preclinical observations.
Jackman AL; Kimbell R; Ford HE
Eur J Cancer; 1999 Mar; 35 Suppl 1():S3-8. PubMed ID: 10645207
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
Cunningham D; Zalcberg J; Maroun J; James R; Clarke S; Maughan TS; Vincent M; Schulz J; González Barón M; Facchini T
Eur J Cancer; 2002 Mar; 38(4):478-86. PubMed ID: 11872339
[TBL] [Abstract][Full Text] [Related]
20. Raltitrexed-based chemotherapy for advanced colorectal cancer.
Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
